Targeted focal therapy for prostate cancer: a review of the literature
- PMID: 21789063
- PMCID: PMC3126059
- DOI: 10.1177/1756287209338708
Targeted focal therapy for prostate cancer: a review of the literature
Abstract
Improvements in prostate cancer diagnosis and treatment have resulted in a decreasing age-adjusted death rate. But improved diagnostic tools have not delivered a proportionate decrease in mortality, primarily because physicians now are diagnosing - and treating - more clinically insignificant tumors. Targeted focal therapy (TFT) uses three dimensional (3D) mapping biopsies to guide cryotherapy so that it targets lesions themselves while sparing surrounding healthy tissues, thereby avoiding side effects associated with more invasive treatments. As such, TFT can provide a bridge between active surveillance and more aggressive treatments for patients with low-risk tumors. It is appropriate for men who either do not want or are not good candidates for more aggressive therapies. Identifying patients who are appropriate candidates for TFT is challenging, but the mapping biopsy technique helps identify individuals who have localized disease and could benefit from this treatment. In recent years, improvements in cryotherapy have increased its efficacy while decreasing complications. At the present time using cryotherapy to target and destroy the cancer(s) is appealing. Other approaches to less aggressive therapies are discussed including gland hemi ablation, high intensity ultrasound (HIFU) and others. Going forward, patients will benefit further from development of better imaging technologies and completion of long-term survival studies.
Keywords: PSA screening; cryotherapy; digital rectal examination; prostate cancer; targeted focal therapy (TFT); transrectal ultrasound.
Figures



Similar articles
-
Targeted focal therapy for prostate cancer: a review.Curr Opin Urol. 2009 May;19(3):283-9. doi: 10.1097/MOU.0b013e32832a2c4a. Curr Opin Urol. 2009. PMID: 19357510 Review.
-
New treatments for localized prostate cancer.Urology. 2008 Dec;72(6 Suppl):S36-43. doi: 10.1016/j.urology.2008.08.506. Urology. 2008. PMID: 19095127
-
Evaluating localized prostate cancer and identifying candidates for focal therapy.Urology. 2008 Dec;72(6 Suppl):S12-24. doi: 10.1016/j.urology.2008.10.004. Urology. 2008. PMID: 19095124
-
A Multicentre Study of 5-year Outcomes Following Focal Therapy in Treating Clinically Significant Nonmetastatic Prostate Cancer.Eur Urol. 2018 Oct;74(4):422-429. doi: 10.1016/j.eururo.2018.06.006. Epub 2018 Jun 28. Eur Urol. 2018. PMID: 29960750 Free PMC article.
-
Focal therapy for localized prostate cancer in the era of routine multi-parametric MRI.Prostate Cancer Prostatic Dis. 2020 Jun;23(2):232-243. doi: 10.1038/s41391-020-0206-6. Epub 2020 Feb 12. Prostate Cancer Prostatic Dis. 2020. PMID: 32051551 Review.
Cited by
-
Initial Experience of Targeted Focal Interstitial Laser Ablation of Prostate Cancer with MRI Guidance.Curr Urol. 2015 Dec;8(4):199-207. doi: 10.1159/000365717. Epub 2015 Nov 10. Curr Urol. 2015. PMID: 30263027 Free PMC article.
-
Low temperature plasma: a novel focal therapy for localized prostate cancer?Biomed Res Int. 2014;2014:878319. doi: 10.1155/2014/878319. Epub 2014 Mar 13. Biomed Res Int. 2014. PMID: 24738076 Free PMC article. Review.
-
Low-temperature plasma treatment induces DNA damage leading to necrotic cell death in primary prostate epithelial cells.Br J Cancer. 2015 Apr 28;112(9):1536-45. doi: 10.1038/bjc.2015.113. Epub 2015 Apr 2. Br J Cancer. 2015. PMID: 25839988 Free PMC article.
-
The role of targeted focal therapy in the management of low-risk prostate cancer: update on current challenges.Prostate Cancer. 2012;2012:587139. doi: 10.1155/2012/587139. Epub 2012 Dec 31. Prostate Cancer. 2012. PMID: 23346405 Free PMC article.
References
-
- Babaian R.J., Donnelly B., Bahn D., Baust J.G., Dineen M., Ellis D., et al. (2008) Best Practice Statement on Cryosurgery for the Treatment of Localized Prostate Cancer. J Urol 180: 1993–2004 - PubMed
-
- Bahn D.K., Silverman P., Lee F., Sr,, Badalament R., Bahn E.D., Rewcastle J.C. (2006) Focal prostate cryoablation: Initial results show cancer control and potency preservation. J Endourol 20(9): 688–692 - PubMed
-
- Barzell W.E., Whitmore III W.F., Andriole G.L. (2003) How to perform transperineal saturation prostate biopsy: technique addresses diagnostic, therapeutic dilemmas that arise following TRUS biopsies. Urology Times 31: 41–41
-
- Bastacky S.I., Wonjno K.U., Walsh P.C., Carmichael M.J., Epstein J.I. (1995) Pathological features of hereditary prostate cancer. J Urol 153: 987–992 - PubMed
-
- Crawford E.D., Barqawi A. (2007) Targeted Focal Therapy: A minimally invasive Ablation Technique for Early Prostate Cancer. Oncology 21(1): 27–32 - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous